149 related articles for article (PubMed ID: 20036893)
1. New advances in clinical biomarkers in testis cancer.
Favilla V; Cimino S; Madonia M; Morgia G
Front Biosci (Elite Ed); 2010 Jan; 2(2):456-77. PubMed ID: 20036893
[TBL] [Abstract][Full Text] [Related]
2. A novel double staining strategy for improved detection of testicular carcinoma in situ cells in human semen samples.
Nielsen JE; Kristensen DM; Almstrup K; Jørgensen A; Olesen IA; Jacobsen GK; Horn T; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
Andrologia; 2012 Apr; 44(2):78-85. PubMed ID: 21486421
[TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of a new human extragonadal germ cell line, SEM-1, and its comparison with TCam-2 and JKT-1.
Russell SM; Lechner MG; Mokashi A; Megiel C; Jang JK; Taylor CR; Looijenga LH; French CA; Epstein AL
Urology; 2013 Feb; 81(2):464.e1-9. PubMed ID: 23374840
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility of novel stem cell markers SALL4, OCT4, NANOG, SOX2, UTF1, and TCL1 in primary mediastinal germ cell tumors.
Liu A; Cheng L; Du J; Peng Y; Allan RW; Wei L; Li J; Cao D
Am J Surg Pathol; 2010 May; 34(5):697-706. PubMed ID: 20410807
[TBL] [Abstract][Full Text] [Related]
5. Towards a non-invasive method for early detection of testicular neoplasia in semen samples by identification of fetal germ cell-specific markers.
Hoei-Hansen CE; Carlsen E; Jorgensen N; Leffers H; Skakkebaek NE; Rajpert-De Meyts E
Hum Reprod; 2007 Jan; 22(1):167-73. PubMed ID: 16920726
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic markers for germ cell neoplasms: from placental-like alkaline phosphatase to micro-RNAs.
Rajpert-De Meyts E; Nielsen JE; Skakkebaek NE; Almstrup K
Folia Histochem Cytobiol; 2015; 53(3):177-88. PubMed ID: 26306513
[TBL] [Abstract][Full Text] [Related]
7. Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors.
Santagata S; Ligon KL; Hornick JL
Am J Surg Pathol; 2007 Jun; 31(6):836-45. PubMed ID: 17527070
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of markers M2A, OCT3/4, AP-2gamma, PLAP and c-KIT in the detection of extragonadal seminomas.
Biermann K; Klingmüller D; Koch A; Pietsch T; Schorle H; Büttner R; Zhou H
Histopathology; 2006 Sep; 49(3):290-7. PubMed ID: 16918976
[TBL] [Abstract][Full Text] [Related]
9. [Tumor markers in testicular cancer].
Mann K
Urologe A; 1990 Mar; 29(2):77-86. PubMed ID: 2158684
[TBL] [Abstract][Full Text] [Related]
10. Significance of placental alkaline phosphatase (PLAP) in the monitoring of patients with seminoma.
Koshida K; Uchibayashi T; Yamamoto H; Hirano K
Br J Urol; 1996 Jan; 77(1):138-42. PubMed ID: 8653285
[TBL] [Abstract][Full Text] [Related]
11. Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers.
Hoei-Hansen CE; Kraggerud SM; Abeler VM; Kaern J; Rajpert-De Meyts E; Lothe RA
Mol Cancer; 2007 Feb; 6():12. PubMed ID: 17274819
[TBL] [Abstract][Full Text] [Related]
12. Analysis of POU5F1, c-Kit, PLAP, AP2γ and SALL4 in gonocytes of patients with cryptorchidism.
Vigueras-Villaseñor RM; Cortés-Trujillo L; Chávez-Saldaña M; Vázquez FG; Carrasco-Daza D; Cuevas-Alpuche O; Rojas-Castañeda JC
Acta Histochem; 2015 Oct; 117(8):752-61. PubMed ID: 26315991
[TBL] [Abstract][Full Text] [Related]
13. New simple and rapid method for purification of mesenchymal stem cells from the human umbilical cord Wharton jelly.
Montanucci P; Basta G; Pescara T; Pennoni I; Di Giovanni F; Calafiore R
Tissue Eng Part A; 2011 Nov; 17(21-22):2651-61. PubMed ID: 21679124
[TBL] [Abstract][Full Text] [Related]
14. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
Neumann A; Keller T; Jocham D; Doehn C
Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
[TBL] [Abstract][Full Text] [Related]
15. New immunohistochemical markers in testicular tumors.
Iczkowski KA; Butler SL
Anal Quant Cytol Histol; 2006 Aug; 28(4):181-7. PubMed ID: 16927637
[TBL] [Abstract][Full Text] [Related]
16. The search for biomarkers of metastatic seminoma.
Ruf CG; Khalili-Harbi N; Sachs S; Isbarn H; Wagner W; Matthies C; Meineke V; Fisch M; Chun FK; Abend M
J Urol; 2013 Sep; 190(3):1046-51. PubMed ID: 23583226
[TBL] [Abstract][Full Text] [Related]
17. Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours.
Hoei-Hansen CE; Almstrup K; Nielsen JE; Brask Sonne S; Graem N; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
Histopathology; 2005 Jul; 47(1):48-56. PubMed ID: 15982323
[TBL] [Abstract][Full Text] [Related]
18. Serum tumour markers in germ cell tumours: From diagnosis to cure.
Pedrazzoli P; Rosti G; Soresini E; Ciani S; Secondino S
Crit Rev Oncol Hematol; 2021 Mar; 159():103224. PubMed ID: 33493632
[TBL] [Abstract][Full Text] [Related]
19. Application of stem cell markers in search for neoplastic germ cells in dysgenetic gonads, extragonadal tumours, and in semen of infertile men.
Hoei-Hansen CE
Cancer Treat Rev; 2008 Jun; 34(4):348-67. PubMed ID: 18289797
[TBL] [Abstract][Full Text] [Related]
20. The value of positive Oct3/4 and D2-40 immunohistochemical expression in prediction of germ cell neoplasia in prepubertal boys with cryptorchidism.
Clasen-Linde E; Kvist K; Cortes D; Thorup J
Scand J Urol; 2016; 50(1):74-9. PubMed ID: 26389689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
